219 related articles for article (PubMed ID: 35220449)
1. Drug-coated balloons for small coronary artery disease in patients with chronic kidney disease: a pre-specified analysis of the BASKET-SMALL 2 trial.
Mahfoud F; Farah A; Ohlow MA; Mangner N; Wöhrle J; Möbius-Winkler S; Weilenmann D; Leibundgut G; Cuculi F; Gilgen N; Kaiser C; Cattaneo M; Scheller B; Jeger RV
Clin Res Cardiol; 2022 Jul; 111(7):806-815. PubMed ID: 35220449
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2.
Mangner N; Farah A; Ohlow MA; Möbius-Winkler S; Weilenmann D; Wöhrle J; Linke A; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Scheller B; Jeger RV;
Circ Cardiovasc Interv; 2022 Feb; 15(2):e011325. PubMed ID: 35000455
[TBL] [Abstract][Full Text] [Related]
4. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B;
Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854
[TBL] [Abstract][Full Text] [Related]
5. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
[TBL] [Abstract][Full Text] [Related]
6. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.
Shin ES; Jun EJ; Kim S; Kim B; Kim TH; Sohn CB; Her AY; Park Y; Cho JR; Jeong YH; Choi BJ
JACC Cardiovasc Interv; 2023 Feb; 16(3):292-299. PubMed ID: 36609038
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.
Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S
Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
9. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
10. Drug-Coated Balloon for Small Coronary Artery Disease in Patients With and Without High-Bleeding Risk in the BASKET-SMALL 2 Trial.
Scheller B; Rissanen TT; Farah A; Ohlow MA; Mangner N; Wöhrle J; Möbius-Winkler S; Weilenmann D; Leibundgut G; Cuculi F; Gilgen N; Coslovsky M; Mahfoud F; Jeger RV;
Circ Cardiovasc Interv; 2022 Apr; 15(4):e011569. PubMed ID: 35411792
[TBL] [Abstract][Full Text] [Related]
11. Drug-coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET-SMALL 2.
Gilgen N; Farah A; Scheller B; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Jamshidi P; Leibundgut G; Möbius-Winkler S; Zweiker R; Krackhardt F; Butter C; Bruch L; Kaiser C; Hoffmann A; Rickenbacher P; Mueller C; Stephan FP; Coslovsky M; Jeger R;
Clin Cardiol; 2018 May; 41(5):569-575. PubMed ID: 29527709
[TBL] [Abstract][Full Text] [Related]
12. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881
[TBL] [Abstract][Full Text] [Related]
13. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
Sanz Sánchez J; Chiarito M; Cortese B; Moretti A; Pagnotta P; Reimers B; Stefanini GG; Ferrante G
Catheter Cardiovasc Interv; 2021 Jul; 98(1):66-75. PubMed ID: 32592437
[TBL] [Abstract][Full Text] [Related]
14. Drug-Coated Balloon Angioplasty for De Novo Lesions on the Left Anterior Descending Artery.
Gitto M; Sticchi A; Chiarito M; Novelli L; Leone PP; Mincione G; Oliva A; Condello F; Rossi ML; Regazzoli D; Gasparini G; Cozzi O; Stefanini GG; Condorelli G; Reimers B; Mangieri A; Colombo A
Circ Cardiovasc Interv; 2023 Dec; 16(12):e013232. PubMed ID: 37874646
[TBL] [Abstract][Full Text] [Related]
15. Drug-Coated Balloon and Drug-Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease.
Hanna J; Smolderen KG; Castro-Dominguez Y; Romain G; Lee M; Turner J; Mena-Hurtado C
J Am Heart Assoc; 2023 Apr; 12(7):e028622. PubMed ID: 36974774
[TBL] [Abstract][Full Text] [Related]
16. Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial.
Rubini Gimenez M; Scheller B; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Cattaneo M; Gilgen N; Kaiser C; Jeger RV
Clin Res Cardiol; 2023 Jul; ():. PubMed ID: 37495797
[TBL] [Abstract][Full Text] [Related]
17. Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial.
Fahrni G; Scheller B; Coslovsky M; Gilgen N; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Zweiker R; Twerenbold R; Kaiser C; Jeger R;
Clin Res Cardiol; 2020 Sep; 109(9):1114-1124. PubMed ID: 31993736
[TBL] [Abstract][Full Text] [Related]
18. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease.
Her AY; Shin ES; Kim S; Kim B; Kim TH; Sohn CB; Choi BJ; Park Y; Cho JR; Jeong YH
Cardiovasc Diabetol; 2023 May; 22(1):120. PubMed ID: 37210516
[TBL] [Abstract][Full Text] [Related]
19. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
[TBL] [Abstract][Full Text] [Related]
20. Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease.
Megaly M; Buda K; Saad M; Tawadros M; Elbadawi A; Basir M; Abbott JD; Rinfret S; Alaswad K; Brilakis ES
Cardiovasc Revasc Med; 2022 Feb; 35():76-82. PubMed ID: 33858783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
